• 1054 Citations
  • 16 Scopus h-Index
20012019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Han W Tun is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Lymphoma Medicine & Life Sciences
Central Nervous System Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Neurology Chemical Compounds
Tumors Chemical Compounds
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 1054 Citations
  • 16 Scopus h-Index
  • 53 Article
  • 1 Letter

Autologous Stem Cell Transplantation in Central Nervous System Lymphoma: A Multicenter Retrospective Series and a Review of the Literature

Dholaria, B. R., Kumar, A., Azzuqua, A. G., Nishihori, T., Kharfan-Dabaja, M. A., Tun, H. W. & Ayala, E., Jan 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Lymphoma
Central Nervous System
Confidence Intervals
Recurrence

Introduction of novel agents in the treatment of primary CNS lymphoma

Grommes, C., Nayak, L., Tun, H. W. & Batchelor, T. T., Jan 1 2019, In : Neuro-oncology. 21, 3, p. 306-313 8 p.

Research output: Contribution to journalArticle

Lymphoma
Central Nervous System
Clinical Trials
Phosphatidylinositol 3-Kinase
Immune Evasion

Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells

Kharfan-Dabaja, M. A., Jain, M. D., Aulakh, S., Ayala, E., Zubair, A., Tun, H. W., Liu, H. D., Locke, F. L. & Chavez, J. C., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalLetter

Open Access
Follicular Lymphoma
Therapeutics
obinutuzumab

Pomalidomide alters pancreatic macrophage populations to generate an immune-responsive environment at precancerous and cancerous lesions

Bastea, L. I., Liou, G. Y., Pandey, V., Fleming, A. K., Von Roemeling, C. A., Doeppler, H., Li, Z., Qiu, Y., Edenfield, B., Copland, J. A. III., Tun, H. W. & Storz, P., Apr 1 2019, In : Cancer Research. 79, 7, p. 1535-1548 14 p.

Research output: Contribution to journalArticle

Open Access
Macrophages
Pancreatic Neoplasms
Population
Immunosuppressive Agents
Neoplasms
7 Citations (Scopus)

Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy

von Roemeling, C. A., Caulfield, T., Marlow, L., Bok, I., Wen, J., Miller, J. L., Hughes, R., Hazlehurst, L., Pinkerton, A. B., Radisky, D. C., Tun, H. W., Kim, Y. S. B., Lane, A. L. & Copland, J. A. III., Jan 1 2018, In : Oncotarget. 9, 1, p. 3-20 18 p.

Research output: Contribution to journalArticle

Stearoyl-CoA Desaturase
Drug Design
Enzyme Inhibitors
Drug Discovery
Toxicology